Literature DB >> 8660078

Does BCG vaccine prevent tuberculous meningitis?

N Thilothammal1, P V Krishnamurthy, D K Runyan, K Banu.   

Abstract

The reported efficacy of BCG vaccine in preventing pulmonary tuberculosis varies from 0-80%; however, its efficacy in preventing tuberculous meningitis ranges from 52%-84%. A case-control study was conducted to assess the efficacy of BCG in preventing tuberculous meningitis in children. New cases of tuberculous meningitis, confirmed bacteriologically, were registered as cases. Controls were children suffering from febrile convulsions attending the same hospital. A total of 107 cases and 321 controls, block matched for age, were registered. Vaccination status was determined from the history reported by the mother and by BCG scar reading. Data regarding socioeconomic status, crowding, and nutritional status were collected. Using multiple logistic regression analysis the odds ratio obtained for the presence of BCG scar was 0.23 (95% confidence interval (CI) 0.14 to 0.37) and the protective efficacy of BCG vaccine in preventing tuberculous meningitis in children was found to be 77% (95% CI 71 to 83%).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8660078      PMCID: PMC1511494          DOI: 10.1136/adc.74.2.144

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  8 in total

1.  Case-control study on evaluation of BCG vaccination of newborn in Rangoon, Burma.

Authors:  T T Myint; H Win; H H Aye; T O Kyaw-Mint
Journal:  Ann Trop Paediatr       Date:  1987-09

Review 2.  The current status of BCG immunization against tuberculosis.

Authors:  T C Eickhoff
Journal:  Annu Rev Med       Date:  1977       Impact factor: 13.739

Review 3.  Present knowledge of immunization against tuberculosis.

Authors:  H G Dam; K Toman; K L Hitze; J Guld
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

4.  The BCG controversy. A methodological and statistical reappraisal.

Authors:  J D Clemens; J J Chuong; A R Feinstein
Journal:  JAMA       Date:  1983-05-06       Impact factor: 56.272

5.  Epidemiological evaluation of BCG vaccine efficacy in Delhi--1989.

Authors:  R S Sharma; D K Srivastava; A A Singh; R K Kumaraswamy; D N Mullick; N Rungsung; A K Datta; G C Bhuiya; K K Datta
Journal:  J Commun Dis       Date:  1989-09

6.  Effectiveness of BCG vaccination against tuberculous meningitis: a case-control study in São Paulo, Brazil.

Authors:  V Wünsch Filho; E A de Castilho; L C Rodrigues; S R Huttly
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

7.  Three chemotherapy studies of tuberculous meningitis in children.

Authors:  P Ramachandran; M Duraipandian; M Nagarajan; R Prabhakar; C V Ramakrishnan; S P Tripathy
Journal:  Tubercle       Date:  1986-03

8.  Risk assessment for acquiring meningitis tuberculosis among children not vaccinated with BCG: a case-control study.

Authors:  P A Camargos; M D Guimaraes; C M Antunes
Journal:  Int J Epidemiol       Date:  1988-03       Impact factor: 7.196

  8 in total
  5 in total

1.  Safety and effectiveness of BCG vaccination in preterm babies.

Authors:  S Thayyil-Sudhan; A Kumar; M Singh; V K Paul; A K Deorari
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-07       Impact factor: 5.747

Review 2.  Does neonatal BCG vaccination protect against tuberculous meningitis?

Authors:  V Walker; G Selby; I Wacogne
Journal:  Arch Dis Child       Date:  2006-09       Impact factor: 3.791

3.  Approach to the Diagnosis and Management of Tuberculous Meningitis.

Authors:  Scott W. Sinner; Allan R. Tunkel
Journal:  Curr Infect Dis Rep       Date:  2002-08       Impact factor: 3.725

Review 4.  Central nervous system tuberculosis: pathogenesis and clinical aspects.

Authors:  R Bryan Rock; Michael Olin; Cristina A Baker; Thomas W Molitor; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

5.  Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis.

Authors:  T Mark Doherty; Anja Weinrich Olsen; Laurens van Pinxteren; Peter Andersen
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.